Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors

J Comput Chem. 2017 Jun 5;38(15):1209-1228. doi: 10.1002/jcc.24728. Epub 2017 Jan 28.

Abstract

Following insights from recent crystal structures of the muscarinic acetylcholine receptor, binding modes of Positive Allosteric Modulators (PAMs) were predicted under the assumption that PAMs should bind to the extracellular surface of the active state. A series of well-characterized PAMs for adenosine (A1 R, A2A R, A3 R) and muscarinic acetylcholine (M1 R, M5 R) receptors were modeled using both rigid and flexible receptor CHARMM-based molecular docking. Studies of adenosine receptors investigated the molecular basis of the probe-dependence of PAM activity by modeling in complex with specific agonist radioligands. Consensus binding modes map common pharmacophore features of several chemical series to specific binding interactions. These models provide a rationalization of how PAM binding slows agonist radioligand dissociation kinetics. M1 R PAMs were predicted to bind in the analogous M2 R PAM LY2119620 binding site. The M5 R NAM (ML-375) was predicted to bind in the PAM (ML-380) binding site with a unique induced-fit receptor conformation. © 2017 Wiley Periodicals, Inc.

Keywords: Cl-IB-MECA; LUF6000; MRS-542; inosine; ischemic.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Allosteric Regulation / drug effects*
  • Allosteric Site / drug effects
  • Humans
  • Models, Molecular
  • Molecular Docking Simulation
  • Muscarinic Agonists / chemistry
  • Muscarinic Agonists / pharmacology*
  • Purinergic P1 Receptor Agonists / chemistry
  • Purinergic P1 Receptor Agonists / pharmacology*
  • Receptors, Muscarinic / chemistry
  • Receptors, Muscarinic / metabolism*
  • Receptors, Purinergic P1 / chemistry
  • Receptors, Purinergic P1 / metabolism*

Substances

  • Muscarinic Agonists
  • Purinergic P1 Receptor Agonists
  • Receptors, Muscarinic
  • Receptors, Purinergic P1